1. What Is the AI in Genomics Market?
The AI in Genomics Market covers machine learning and deep learning platforms applied to genomic sequence analysis, variant interpretation, gene expression profiling, and multi-omics data integration. AI genomics encompasses deep learning variant calling algorithms, polygenic risk score models, genome-wide association study AI interpretation tools, and single-cell sequencing analysis platforms. Market dynamics reflect sequencing cost decline increasing dataset scale, clinical genomics interpretation bottlenecks driving AI variant prioritisation, and pharmaceutical genomic biomarker discovery investment.
2. AI in Genomics Market Size & Forecast
3. Emerging Technologies
- AI variant classification tools automatically interpreting VUS (variants of uncertain significance) using multi-source evidence integration are advancing as clinical genomics reporting tools. Growing laboratory adoption is driven by VUS resolution requirements for clinical report utility.
- Foundation models pre-trained on billion-base-pair genomic sequences for transfer to specific genomic tasks are advancing as general-purpose genomics AI. Growing research adoption at genome institutes is driven by sequence-to-function prediction capability.
- AI spatial transcriptomics analysis integrating tissue gene expression maps with variant data are advancing as precision oncology tissue characterisation tools. Growing pharma adoption is driven by tumour microenvironment characterisation requirements.
- Federated genomic AI enabling multi-biobank model training without data sharing are advancing as privacy-preserving population genomics infrastructure. Growing adoption at national genome programmes is driven by governance constraints on cross-border data access.
Similar technologies are also transforming adjacent markets. Learn more in our AI In Medical Imaging Market.
4. Key Market Opportunity
The primary growth driver in the AI in Genomics Market is the clinical genomics interpretation sub-market, where the growing volume of whole-genome and exome sequencing in clinical diagnostics creates sustained demand for AI variant interpretation platforms at laboratory scale. Pharmaceutical genomic biomarker discovery creates high-margin revenue for AI genomics companies partnering with drug developers to identify patient stratification signatures. Population genomics AI for national biobank and screening programmes creates a stable government-funded revenue channel as countries launch genome sequencing initiatives. Asia Pacific genomics AI adoption creates geographic opportunity as China, Japan, and India launch national genomics programmes requiring AI interpretation infrastructure.
5. Top Companies in the AI in Genomics Market
The following organisations hold leading positions in the AI in Genomics Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Illumina (DRAGEN)
- Google (DeepVariant)
- Sentieon
- SOPHiA GENETICS
- PierianDx
- Genomics England (PRS)
- Tempus
- Foundation Medicine (Roche)
- Human Longevity
- Variantyx
6. Market Segmentation
The AI in Genomics Market is analysed across 4 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Application | Variant InterpretationPolygenic Risk ScoringGWAS AIscRNA AnalysisMulti-Omics Integration |
| By Segment | Clinical GenomicsResearch GenomicsOncogenomicsPopulation Genomics |
| By End User | Clinical LabsResearch InstitutesPharma and BiotechDirect-to-Consumer Genetics |
| By Geography | North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the AI in Genomics Market trajectory over the forecast period:
DeepVariant AI Achieves Near-Perfect Accuracy in Germline Variant Calling From Short-Read Sequencing.Google's DeepVariant deployed in clinical sequencing workflows at over 200 genomics laboratories by 2024 achieves 99.7 percent variant calling accuracy, outperforming traditional GATK pipelines. Clinical laboratory integration of DeepVariant reducing false-positive variant calls by 40 percent versus statistical callers demonstrates the clinical diagnostic utility of deep learning genomics.
AlphaFold 3 Integration With Genomics AI Is Accelerating Disease Gene Function Prediction.Research teams at the Wellcome Sanger Institute and Broad Institute integrating DeepMind's AlphaFold 3 with genomic variant datasets in 2024 predicted variant protein impact without experimental validation. Pharmaceutical companies including Novartis and Pfizer using AI variant-function prediction to prioritise rare disease gene therapy targets are creating early commercial adoption of AI genomics.
Polygenic Risk Score AI Models Are Entering Clinical Practice for Cardiovascular and Cancer Risk Stratification.Genomics England's PRS programmes and UK Biobank AI polygenic models validated in 2024 identified top 5 percent cardiovascular risk individuals with 4.6x relative coronary artery disease risk. UK NHS piloting AI PRS for breast cancer risk screening stratification in 2024 demonstrates the first national health system adoption of population-scale AI genomic risk models.
For related market intelligence, see the AI In Proteomics Market.
8. Segmental Analysis
By application, the Variant Interpretation and VUS Resolution segment dominated the AI in Genomics Market in 2025. Representing the largest revenue category as clinical genomics laboratories adopting AI reporting tools reduce manual curation time per case. The Polygenic Risk Scoring segment is the fastest-growing category, advancing as national screening programmes and direct-to-consumer genomics integrate AI PRS for disease risk stratification.
By segment, the Clinical Genomics segment dominated the AI in Genomics Market in 2025. Representing the largest segment revenue share. The Oncogenomics segment is the fastest-growing segment category, advancing as precision oncology biomarker adoption scales. The Oncogenomics growth rate is outpacing the overall AI in Genomics Market average, gradually shifting segment revenue composition through 2034.
By end user, the Clinical Labs segment dominated the AI in Genomics Market in 2025, as clinical genetics and molecular diagnostic laboratories generate the highest genomic AI interpretation platform deployment. Research Institutes are the fastest-growing end-user category, driven by human cell atlas, population genomics, and single-cell biology programmes scaling AI variant analysis.
9. Regional Analysis
Regional demand patterns across the AI in Genomics Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America accounted for the largest share of the AI in Genomics Market in 2025, holding 46.2% of the global market. Clinical genetics laboratories, biotech companies, and population health programmes are deploying AI genomics platforms to accelerate variant interpretation, rare disease diagnosis, and pharmacogenomics analysis at scale. FDA regulatory frameworks for AI-based genetic testing and NIH precision medicine investment are encouraging healthcare systems and research institutions to build AI genomics capabilities. High genomic testing volumes, growing consumer genetic awareness, and expanding oncology genomics adoption are generating strong demand for AI-powered interpretation and clinical decision tools.
Highest CAGR Region
Asia Pacific is expected to register the highest CAGR of 26.16% during the forecast period. Government-funded national genomics programmes across China, India, Japan, and Australia are creating large-scale biobank datasets that are enabling AI model development and commercial genomics platform adoption. Growing pharmaceutical investment in pharmacogenomics research and increasing clinical adoption of companion diagnostics requiring genetic analysis are accelerating AI genomics deployment across the region. Rising consumer genomics adoption and expanding direct-to-consumer genetic testing availability are generating end-user demand for AI-powered personal genomics interpretation capabilities.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The AI in Genomics Market was valued at USD 1.12 Bn in 2025 and is projected to reach USD 6.50 Bn by 2034, growing at a CAGR of 21.6% over the 2026–2034 forecast period.
The AI in Genomics Market is projected to grow at a CAGR of 21.6% from 2026 to 2034.
North America accounted for the largest share of the AI in Genomics Market in 2025, holding 46.2% of the global market.
The leading companies in the AI in Genomics Market include Illumina (DRAGEN), Google (DeepVariant), Sentieon, SOPHiA GENETICS, PierianDx, Genomics England (PRS), Tempus, Foundation Medicine (Roche), Human Longevity, Variantyx.
Deepvariant ai achieves near-perfect accuracy in germline variant calling from short-read sequencing.
By application, the Variant Interpretation and VUS Resolution segment dominated the AI in Genomics Market in 2025.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.